CRL

Charles River Laboratories International, Inc. | Cotação de Ações

Última atualização19/09/2025, 12:55:16

PreçoUS$ 153,76

Variação (dia)-US$ 3,24 (-2.06%)▼

Min. 52 SemanasUS$ 91,86

Máx. 52 SemanasUS$ 230,02

Capitalização de mercado--

Endereço: 251 Ballardvale Street, Wilmington, MA, 01887

Telefone: 781 222 6000

Funcionários: 18.700

Charles River Laboratories InteCRL

US$ 153,76

- 3,2352,1%

19/09/2025 12:55:16

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 153,76

Valor de mercado--

AberturaUS$ 153,05

Preço máximoUS$ 157,26

Preço mínimoUS$ 153,21

VolumeUS$ 475 mil

Fechamento anteriorUS$ 156,99

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Ações relacionadas

Bio-Techne Corporation

TECH ▼0.04% | US$ 78,71

IQVIA Holdings Inc.

IQV ▼0.27% | US$ 205,42

The Cooper Companies, Inc.

COO ▼0.17% | US$ 95,18

Bio-Rad Laboratories, Inc.

BIO ▲6.68% | US$ 360,54

West Pharmaceutical Services, Inc.

WST ▲3.18% | US$ 347,87

Descubra as últimas atualizações do mercado de ações, incluindo os preços de empresas como Magazine Luiza (MGLU3) e Petrobras (PETR4)

Mantenha-se informado sobre o mercado de ações com as atualizações da brapi. Em nossa seção de notícias, fornecemos análises profundas sobre empresas líderes, como Magazine Luiza e Petrobras, auxiliando em decisões de investimento mais esclarecidas.

Saiba mais sobre a brapi e nossa missão de fornecer informações confiáveis

Entenda a missão da brapi em fornecer informações estritamente informativas de fontes confiáveis. Valorizamos a transparência e a responsabilidade, incentivando investidores a buscar aconselhamento financeiro independente para decisões informadas.

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.